featured
featured Articles
Snap stock has rallied, headed toward a 52-week high. Comments from senior management were probably the primary reason the shares advanced.
Published:
Shopify is set to deliver its fourth-quarter earnings report ahead of Wednesday's open, and it will have to do far better than merely meeting expectations to keep investors and the momentum investing...
Published:
With its shares up over 30% year to date and an encouraging forecast for the rest of the year, analysts and investors have been jumping back on the Uber ride.
Published:
Restaurant Brands saw systemwide sales grow 10% in the fourth quarter, due in part to the surprising popularity of the Popeyes chicken sandwich.
Published:
Russia continues to resist moving up a March meeting of OPEC+ oil ministers to deal with the falling demand for crude caused by the coronavirus outbreak. There are several reasons for that.
Published:
After posting poor earnings results for last year, Ford promoted an executive who has been with the company for 12 years. It is a wonder it did not look outside the company for fresh blood.
Published:
The odds that McClatchy papers will be sold is high, and there is already a list of potential buyers.
Published:
24/7 Wall St. has put together a preview of Cisco, Lyft, Nvidia and a few of the other most anticipated quarterly reports due this week.
Published:
The quest for racial equality and justice in the United States has been long and divisive. As we celebrate Black History month, 24/7 Tempo has created a list of the most important moments of the...
Published:
The U.S. unemployment rate was 3.5% in December 2019, unchanged from the multi-decade low the previous month. While it may be easier for the typical American to find a job today than it has been in...
Published:
The U.S. unemployment rate was 3.5% in December 2019, unchanged from the multi-decade low the previous month. For many working Americans, job security is better now than it has ever been —...
Published:
The cannabis industry got another shock when Aurora Cannabis announced that its founder and chief executive, Terry Booth, would retire. He is the third high-profile CEO of a cannabis company to lose...
Published:
Amarin is a development-stage biotechnology company with one FDA-approved treatment, a cardiovascular disease drug with no real competition. The company looks well-poised to boost sales in 2020 and...
Published:
Investors of Aurora Cannabis, like investors everywhere, are an impatient lot. Wall Street expects profits, and none of these marijuana companies is anywhere near profitability.
Published:
AbbVie released better than expected fourth-quarter financial results before the markets opened on Friday.
Published: